氢化麦角碱治疗糖尿病周围神经病变临床观察  

作　　者：李芳 

机构地区：广西桂林市第二人民医院,541001

出　　处：《中外健康文摘：医药月刊》2008年第2期18-20,共3页

摘　　要：目的研究氢化麦角碱治疗2型糖尿病周围神经病变的治疗效果。方法选择100例糖尿病合并肢体麻木、疼痛、间隙性跛行症状者。随机分为两组，治疗组49例用氢化麦角碱，对照组51例用复方丹参注射液，共用药20天为一疗程。治疗前后检测患者血塘、肝功、肾功、血脂、尿微量白蛋白、四肢多普勒检查以及感觉阈值变化。结果治疗组总有效率77．6％，对照组58．8％（p〈0．05）。氢化麦角除改善上述症状，也改善了下肢血流及神经敏感性，对血糖、血压及尿蛋白均有改善。未发现肝肾功能受损害。结论氢化麦角碱可作为治疗糖尿病周围神经病变的另一种选择。Study the Ergota alkali of hydrogenation and treat the therapeutic effect that neuropathy around changes. Method： Choose 100 cases of diabetes to amalgamate limb numbness, pain, person who walks lamely symptom of intermittence. Divided into two groups immediately, treated 49 groups, used the Ergota alkali of hydrogenation, 51 control groups used parenteral solution of compound root of red-rooted salvia, it is a course of treatment in 20 days. Measure patient＇s blood plasma glucose, liver function, renal function, fat of blood, urine micro- albumen, Doppler＇s inspection of four limbs before and after treating, observe and change. Result： Treat group always efficient 77.6%, control group 58.8% （p〈0.05） . The conclusion is a hydrogenation Ergota alkali family, as treating another choice that neuropathy changes around diabetes,

关 键 词：糖尿病周围神经病变 氢化麦角碱 

分 类 号：R587.1[医药卫生—内分泌;医药卫生—临床医学;医药卫生—内科学]